QQ客服 官方微博 反馈留言

	Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model
	Liu, Meizhou; Zhang, Yangde; Liao, Yunjun; Chen, Yixing; Pan, Yifeng; Tian, Hu; Zhan, Yongqiang; Liu, Dongjing
刊名	Cancer Biotherapy and Radiopharmaceuticals
	2015
卷号	30期号:6页码:233-239
关键词	animal model CDC20 heparanase liver cancer RNA interference
DOI	10.1089/cbr.2014.1799
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4771556
专题	山东大学
作者单位	1.Hepatobiliary Enteric Surgery Research Center, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, China 2.Hepat
推荐引用方式 GB/T 7714	Liu, Meizhou,Zhang, Yangde,Liao, Yunjun,et al. Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model[J]. Cancer Biotherapy and Radiopharmaceuticals,2015,30(6):233-239.
APA	Liu, Meizhou.,Zhang, Yangde.,Liao, Yunjun.,Chen, Yixing.,Pan, Yifeng.,...&Liu, Dongjing.(2015).Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.Cancer Biotherapy and Radiopharmaceuticals,30(6),233-239.
MLA	Liu, Meizhou,et al."Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model".Cancer Biotherapy and Radiopharmaceuticals 30.6(2015):233-239.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。